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Taniguchi  et  al.  (1)  have  shown  that  the  in  vitro antibody  response  of B10 and 
B10-H-2-congenic mouse strains  (B10 strains)  cannot be suppressed  by a  suppressor 
factor from T  cells (TsF)1 that has potent inhibitory effects when tested on cells from 
other mouse strains. This factor, which is keyhole limpet hemocyanin (KLH) specific, 
is extracted by sonication from primed Ly-l-,2  + (Ly-2) T  cells. It induces primed Ly- 
1+,2 +  (Ly-l,2)  T  cells  to help  Ly-2 express  immunosuppressive  activity, and  is  H-2 
restricted  in its action.  This TsF as well  as its producer and  acceptor T  cell  subsets 
bear a  determinant  controlled by the I-J subregion of the H-2 gene complex (2). The 
ability of Ly-l.2 T  cells to be activated by this TsF is regulated by a  locus that is not 
linked to the H-2 gene complex. Cells from B10 strains are capable of producing this 
TsF, but are not suppressed by it.  Failure of the TsF to suppress antibody responses 
of B 10 strain spleen cells has been correlated with an inability of acceptor T  cells to 
absorb the factor. 
Recently, we have described another suppressor factor from Ly-2 T  cells (Ly-2 TsF) 
which  also  fails  to  suppress  in  vitro  antibody  responses  of spleen  cells  from  B10 
strainsfl This factor is similar to one described above in that it is produced by primed 
Ly-2 T  cells, and is H-2 restricted in its action. However, unlike the factor described 
by Tada et al.  (1), the Ly-2 TsF we have studied has the following characteristics:  (a) 
it  is  specific for a  different  antigen  (sheep  erythrocytes  ([SRBC]  vs.  KLH),  (b)  it  is 
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released by immune cells into culture supernates (i.e., it is not physically extracted by 
sonication),  (c)  it acts on  a  different acceptor cell  (unprimed  Ly-l+,Ly-2  -  T  cell set 
[Ly-1]  T  cells vs.  primed  Ly-l,2 T  cells),  (d)  it  does  not  require  Ly-t,2 T  cells to 
express suppressive activity, and  (e) is produced by I-J-;Ly-23 (vs. I-J+;Ly-2) T  cells. 
Mattingly  et  al.  (3)  have  also  described  a  TsF  (SRBC  specific)  that  differs  by 
several criteria from both of the factors described above and that also fails to suppress 
in vitro antibody responses of B 10 strain spleen cells. 
Thus, the inability of various factors to suppress in vitro antibody responses of B 10 
strain spleen cells does not correlate with a unique immunogen or a unique interaction 
site in the suppressor circuit. We therefore felt that if we could determine the nature 
of  the  suppressor  defect  in  B10  strains,  we  might  gain  further  insight  into  the 
mechanism(s) by which TsF work. In particular, we wanted to know if the activity of 
cells in the newly described contrasuppressor circuit (4) 4 could be responsible for the 
failure of B10 strains to respond to TsF. 
The results of our investigation, reported herein,  indicate that  factor preparations 
from  Ly-2 T  cells contain,  in  addition to TsF,  a  second  factor which  is more cross- 
reactive than is Ly-2 TsF (4) and induces contrasuppressor activity (TcsiF). Thus, the 
failure of Ly-2 TsF to suppress B 10 spleen cells responses under ordinary circumstances 
is a  result  of the overriding activity of the contrasuppression  system, which  acts  to 
oppose suppression.  Experimental  maneuvers  that  remove contrasuppressor activity 
render  B10  strains indistinguishable from  other mouse strains in their sensitivity to 
Ly-2 TsF-mediated suppression. 
Materials  and  Methods 
Mice.  C57BL/6 (C57BL/6 ×  B10.A)F1 (B6AF1), and B10.A/Sn mice, 6-10 wk of age, were 
obtained from The Jackson Laboratory, Bar Harbor, Maine. All other strains are maintained 
in our colony at Yale University School of Medicine, New Haven, Conn. 
Antigens.  SRBC and horse erythrocytes (HRBC) were obtained from Colorado Serum Co., 
Denver Colo. 
Antisera.  Anti-Ly-1.2 (C3H/An anti-C3H.CE-Lyt-l.2) and anti-Ly-2.2 (C3H/An × B6-Lyt- 
2.1 anti-ERLD) were prepared and tested for specificity as previously described (5). These sera 
were generously supplied by F.-W. Shen, Memorial Sloan-Kettering Cancer Center, New York. 
Monoclonal anti-Thy-1  reagents were  generously provided by Dr.  Phillip Lake,  University 
College, London and Dr. Jonathan Sprent, University of Pennsylvania, Philadelphia, Pa. Anti- 
I-J  b  serum  was  prepared  by  hyperimmunizing  B10.A(5R)  recipients  with  a  mixture  of 
B 10.A(3R) spleen and lymph node cells (antiserum No. ASM-5). Anti-I-J  k sera were prepared 
by hyperimmunizing B10.A(3R) and [B10.A(3R)  ×  A.BY]F1  (antiserum No. ASM-46) recipi- 
ents with B 10.A(fR) cells (6). 
Method of Cell Preparation.  Spleen cells were washed in balanced salt solution and suspended 
in  RPMI-1640 supplemented with  10%  fetal calf (FCS) serum,  100  mM glutamine, 25  mM 
Hepes, and 5 ×  10-  M  2-mercaptoethanol for tissue culture. T  cells were prepared by adding 
unprimed spleen cells to plastic petri dishes coated with goat anti-mouse immunoglobulin and 
harvesting the nonadherent fraction (7). 
Cytotoxic Depletion of Cells.  Depletion  of cells bearing  a  given  marker  was  achieved  by 
3 The designation "I-J-" is used to indicate that the cell type in question is not killed by complement- 
dependent treatment with our anti-l-J reagents. We cannot exclude the possibility that these I-J- functional 
cell populations  (a) express an I-J determinant not  detected  by our reagents or (b) express insufficient 
amounts of I-J antigen to be killed or bound. 
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incubating cells with antiserum dilution in balanced salt solution (BSS) for 30 min at 37°C (1 
×  107 cells/1  ml of l:20-diluted anti-Ly sera,  1 ×  10  v cells/1  ml of l:l,000-diluted and anti- 
Thy-1 serum, or 1 ×  10  v cells/1 ml of l:5-diluted ant i-I-J serum), washing, and incubating with 
rabbit complement for 45 min at 37°C (1 ×  10  7 cells/1  ml of 1:10-diluted complement). The 
cells were then washed twice in BSS and resuspended in tissue  culture medium (8). 
Pur~'cation by Ly-2 TsF  The detailed method for production of this factor has been described 
elsewhere. 2 Briefly, mice were immunized with 0.2 ml the second immunization. Their spleen 
cells were treated with an anti-Ly-1 serum and rabbit complement (C') and then cultivated in 
vitro  for 48  h  at  1  ×  10  v cells/1  ml  in  RPMI-1640  supplemented  with  10%  FCS.  After 
incubation,  the supernate  was harvested,  centrifuged  at  2,500 rpm  for 20 min,  and  passed 
through a Millipore filter (Millipore Corp., Bedford, Mass.).  (The role of antigen in helping [or 
suppressing] the production of these factors has not yet been fully determined.) 
Absorption of Soluble Factors.  Absorption with erythrocytes was done by mixing 1 ml ofcuhure 
supernates with 0.1  ml of a 50% erythrocyte suspension for 1 h on ice. The erythrocytes were 
removed after centrifugation. For absorption with anti-I-J sera, supernatant fluids were passed 
over anti-I-J immunoabsorbents  prepared  by conjugation of antisera  to cyanogen bromide- 
activated Sepharose. 
Assay Cultures.  Suppressor activity by the supernates of primed, cultured  Ly-2 T  cells was 
determined by adding these materials  to cultures containing unprimed spleen cells  that  had 
been treated with various test reagents. All cells were suspended in RPMI-1640 tissue  culture 
medium (see above), at a concentration of 5 ×  108/1 ml, and  1 ml of the cell suspensions was 
cultured with 0.05  ml of a  1% SRBC suspension in Falcon 3008 plates (Falcon Labware, Div. 
of Becton, Dickenson & Co., Oxnard, Calif.)  in a 5% CO2-95% air incubator at 37°C. At day 
5, the anti-SRBC response was determined by enumerating the number of plaque-forming cells 
(PFC) per culture by the technique of Cunningham and Szenberg (9). 
Results 
Supernates from Cultured Immune Ly-2 T  Cells Fail to Suppress the Primary MisheU-Dutton 
Response of Spleen Cells from BIO Mouse Strains  (Table I).  Results presented in Table I 
demonstrate the phenomenon we are investigating. Supernates from cultured immune 
Ly-2 T  cells (Ly-2 factor preparation),  which have potent suppressive activity at the 
concentrations  used,  when assayed on B6  (experiments  A-C)  or B6AF1  (experiment 
D)  spleen  cells,  fail  to  suppress  responses  by  B10  (experiments  A-C)  or  B10.A 
(experiment  D)  spleen  cells.  Similar results were obtained with  Ly-2 factor prepara- 
tions  from  strains  B6  (experiments  A  and  B),  B10  (experiment  C),  and  B6AF1 
(experiment  D).  Thus,  although  responses  by  B10  and  B10.A  spleen  cells  are  not 
suppressed,  both strains  are capable of producing TsF  (see Table  II for results  with 
B10.A Ly-2 factor preparation). 
Ly-2 Factor Preparations Can Suppress the Response of Spleen Cells from BIO Strains If Ly- 
2 ÷  (Ly-l,2  and  Ly-2)  Cells  are  Removed from  the  Assay  Cultures (Table  II).  Results 
presented  in Table II show that cultures of B10 or B10.A spleen cells depleted of Ly- 
2 +  (Ly-l,2  and  Ly-2)  cells  by  treatment  with  anti-Ly-2  antiserum  plus  C'  (Ly-2- 
spleen  cells)  are  readily  suppressed  by  Ly-2  factor  preparations.  Experiment  D  of 
Table  II shows that  B10.A Ly-2- spleen  cells  are suppressed  as easily as are B6AF~ 
cells  (note the contrast with experiment  D  in Table I; the data come from the same 
experiment).  Experiments E, F, and G  demonstrate that whereas unfractionated B 10 
and B 10.A spleen cells are not suppressed by the Ly-2 factor preparation, Ly-2- spleen 
cell  cultures  are  significantly  suppressed.  Thus,  resting,  nonimmune  Ly-2  +  (Ly-l,2 
and/or Ly-2) cells block Ly-2 factor-mediated suppression  in B 10 strains. 
BIO Strain Ly-2- Spleen Cells Are as Easily Suppressed as Are Ly-2- Spleen Cells of Other 
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TABLE  I 
Supernates from Cultured Immune Ly-2 T Cells Fail to Suppress the Primary 
MisheU-Dutton Response of Spleen Cells  from B I O  Mouse Strains 
Exp.  Spleen cells in  Ly-2 factor prep-  PFC/culture§  Suppres- 
culture*  aration:]:  sion 
% 
B6  -  1,500 
B6  +  (B6)  600  60 
B 10  -  2,400 
B10  +  2,000  17 
B6  --  1,300 
B6  +  (B6)  400  69 
B 10  -  1,000 
BI0  +  900  l0 
C  B6  -  1,900 
B6  +  (B10)  900  53 
B 10  -  850 
B10  +  800  6 
D  B6AF1  -  1,300 
B6AF,  +  (B6AF,)  300  77 
B 10.A  -  1,500 
B10.A  +  1,400  7 
* 5 ×  106 unprimed spleen cells. 
:1: (-) without  or (+)  with culture supernate  from in vivo primed anti-Ly-1 
plus C'-treated spleen cells. Strain source of factor is in parentheses. 
§ Mean PFC of triplicate cultures. 
by B 10 mice of suppression by Ly-2  ÷ ceils is not indirectly caused by an insensitivity 
of their helper cells to TsF. In the absence of Ly-2  ÷ cells, they are at least as sensitive 
to suppressor factor as are B6  Ly-1  helper cells. The maximum  level of suppression 
that can be achieved with Ly-2 TsF seems to be in the 75-80% range,  2 and this level 
is the one we have found in most situations where B10  Ly-2- spleen cells have been 
tested. 
BIO  T  Cells Are More Efficient  in  Contrasuppression Than  Are B6  T  Cells Even When 
Assayed on Ly-2-depleted B6 Spleen Cells (Table IV).  The results in Table IV confirm 
the general conclusion drawn from the results presented in Table III. In addition they 
show that similar numbers of B 10 T  cells exert significantly more contrasuppression 
than  do  B6  T  cells  even  when  added  to  B6  Ly-2-  spleen  cells  in  assay  cultures 
(compare groups 3 and 5 with groups 4 and 6  in Table IV). 
Cells Responsible  for Blocking the Suppressive Activity of Ly-2 Factor Preparations Exhibit the 
Ly-l+,2+;I-J+;Qa-1  ÷ Phenotype (Table  V).  Experiments  designed to  further charac- 
terize  the  cell  surface  phenotype  of  the  Ly-2  +  cells  responsible  for  neutralizing 
suppressive activity (Table V)  show that cells responsible for overcoming suppressor 
activity express, in addition to the Ly-2 alloantigen, the Ly-1 alloantigen (groups 2), 
the Qa-1  alloantigen (group 2a), and an alloantigen controlled by the I-J subregion 
(groups 3). Results listed in groups 4  verify the specificity of the anti-I-J serum. 
In  sum,  data  in  the  preceding  sections  show  that  the  failure  of  Ly-2  factor 
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TABLE  II 
Ly-2 Factor Preparations Can Suppress the Response of Spleen Cells  from B IO 
Strains If Ly-2  + (Ly-l,2 and Ly-2) Cells Are Removed  from the Cultures 
Ly-2 factor  PFC/cul-  Sup- 
Exp.  Spleen cells in culture*  preparation:~  ture§  pres- 
sion 
D  B6AF1  -  1,300 
B6AF1  +  (B6AF1)  300  77 
B10.A Ly-2- spleenl[  -  1,700 
B10.A Ly-2- spIeen[I  +  300  82 
E  B10  -  1,700 
B10  +  (B6)  1,700  0 
B10 Ly-2- spleenl]  -  1,700 
B10 Ly-2- spleenll  +  250  85 
B10.A  -  1,150 
B10.A  +  (B 10.A)  1,300  0 
B 10.A Ly-2- spleen[I  -  850 
B 10.A Ly-2- spleenll  +  200  76 
G  B10  -  2,100 
B10  +  (B6)  2,400  0 
B 10 Ly-2- spleenll  -  2,200 
B l0 Ly-2- spteenll  +  500  77 
* 5 ×  106 unprimed spleen cells. 
~: (-) without  or (+)  with culture supernate  from in vivo primed anti-Ly-1 
plus C'-treated spleen cells. Strain source of factor is in parentheses. 
§ Mean PFC of triplicate cultures. 
11 Spleen cells treated with anti-Ly-2 serum + C'. 
defect in the suppressor system. Rather, Ly- 1  +,2 ÷; I-J  + ;Qa- 1  + T  cells present in normal 
spleen  cell  preparations  interfere  with  suppressor  activity.  Removal  of these  cells 
results in efficient suppressor activity. 
Coupled with our earlier work, which also showed that Ly-l÷,2+;I-J  + T  cells could 
act  to block suppressor cell activity (4),  these results suggest  that  the defect in B10 
strains may be a  result of contrasuppressive activity. To  further  test  this possibility, 
we utilized the knowledge that culture supernates from primed Ly-2 T  cells contain 
two activities; one produced I-J;Ly-2 T  cells (Ly-2 TsF) which suppresses cultures of 
Ly-1  T  cells plus  B  cells and  another  (Ly-2 TcsiF)  produced  by  I-J+;Ly-2 T  ceils 
which induces Ly-2  + T  cells to express contrasuppressive activity. We reasoned that 
if B10  strains  fail to  respond  to  suppressor  factor because of competing contrasup- 
pressor activity, removal of Ly-2 TcsiF-inducing activity from the Ly-2 factor prepa- 
ration would restore suppression. Data in the next three sections show that this is the 
case and provide further information on the nature of Ly-2 TcsiF. 
Spleen  Cells from  BIO  Strains Can  Be  Suppressed by  Factor Preparations from  Cultured 
I-J-;Ly-2  T Cells (Table  VI).  Data in Table VI show that anti-I-J plus C' pretreat- 
ment  of  the  cellular  source  of  TsF  and  TcsiF  eliminates  the  I-J+;Ly-2  T  cells 
responsible for the production of Ly-2 TcsiF but does not hamper the production of 
Ly-2  TsF.  Thus,  Ly-2 TsF  is  inhibitory even  when  assayed on  unfractionated  B10 
strain spleen cells  (experiments  D-G  of Table VI)  when  Ly-2 TcsiF is not  present. 1552  IMMUNOREGULATORY  CIRCUITS  THAT  MODULATE  RESPONSIVENESS 
TABLE  III 
BIO Strain Ly-2- Spleen Cells Are as Easily Suppressed  as Are Ly-2- 
Spleen Cells of Other Mouse Strains 
Ly-2 factor 
Spleen cells in  prepara-  PFC/culture§  Suppression 
culture*  tion~: 
% 
B 10  -  2,400  B 10 standard 
B6  -  1,500  B6  standard 
B10  +  2,000  18 
B6  +  600  60 
B 10 Ly-2-  -  4,300  B 10 standard 
B6 Ly-2-  -  1,400  B6  standard 
B10 Ly-2-  +  1,200  82 
B6 Ly-2-  +  800  43 
* 5 ×  106 unprimed spleen cells. 
:1: (-)  without and (+)  with culture supernate from in vivo primed anti-Ly-1 
plus C'-treated B6 spleen cells. 
§ Mean PFC of triplicate cultures. 
TABLE  IV 
BIO T Cells Are More Efficient m Contrasuppression Than Are B6 T Cells Even When 
Assayed on Ly-2-depleted B6 Spleen Cells 
T  cells added to  Ly-2 fac- 
Ly-2- splenic B6  tor prepa- 





Exp. I  Exp. II  Exp. I  Exp. II 
l  --  -  1,900  1,200  Control 
2  --  +  250  350  Standard 
3  2 x  l05 B6  +  300  ND¶  3  ND 
4  2 x  l05 B10  +  700  ND  28  ND 
5  5 ×  105 B6  +  450  400  13  6 
6  5 ×  105 BI0  +  1,400  1,000  70  76 
* 5 ×  106 unprimed spleen cells. 
(-) without and (+) with culture supernate from in vivo primed anti-Ly-1 plus C'-treated 
B6 spleen cells. 
§ Mean PFC of triplicate cultures. 
]] 100  minus the  ratio  of the  percentage  of suppression  (87  for  experiment  I  and  71  for 
experiment II) of standard to percent suppression of test groups. 
¶ Not determined. 
Experiment J  shows that cells from strain B10.A(3R)  (I-J  b) but not B10.A(5R)  (I-J  k) 
absorb  anti-I-J  b antibody reactive with I-J  b Ly-2 TcsiF-producing cells, verifying the 
specificity of our reagent. Thus, by eliminating the I-J+; Ly-2 T cell that produces Ly- 
2 TcsiF, only Ly-2 TsF is produced. B10 strain responses are readily  suppressed  when 
the contrasuppression system is not activated. 
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TABLE  V 
Cells Responsible  for Blocking the Suppressive Activity of Ly-2 Factor Preparations Exhibit the 
ly- l +,2+;  I-J +; Qa- I ÷ Phenotype 
Mouse  T  cell sets  Ly-2 factor  PFC/cul- 
strain  T  cells in culture*  or subsets  prepara-  ture§  Suppression 
deleted  tion~ 
% 
B10  Group  1 
Unfractionated  None  -  1,600 
+  (B6)  1,900  0 
Group 2 
Mixture of Ly- 1- +  Ly- 1,2  -  1,200 
Ly-2-  +  (B6)  600  50 
Group 3 
Mixture of Ly-2- +  I-J  +  -  1,500 
I-J-  4- (B6)  600  60 
Group 4 
Ly-2- 4- I-J- (control)l  [  None  -  1,400 
+  (B6)  1,400 
Exp. I  Exp. II  Exp. I  Exp. II 
BI0.A  Group  1 
Unfractionated  None  -  1,600  1,400 
+  (B 10.A)  1,500  1,400  6  0 
Group 2 
Mixture of Ly-l- +  Ly-l,2  -  1,000  1,100 
Ly-2-  +  (B 10.A)  300  500  70  55 
Group 2a 
Mixture of Ly-1- +  Qa-1 +  -  1,100  1,000 
Qa-1-  +  (B  lO.A)  400  400  64  60 
Group 3 
Mixture of Ly-2- ÷  I-J  +  -  1,100  1,000 
I-J-  4- (B 10.A)  500  350  55  65 
Group 4 
Mixture of Ly-2- +  None  -  700  900 
I-J- (control)[]  +  (BI0.A)  600  900  15  0 
* All cultures contained 3 ×  106 unprimed B cells and 2 ×  106 total T  cells. All cell mixture ratios were 50: 
50. 
:~ (-)  without or (+)  with culture supernate from in vivo primed anti-Ly-1  plus C'-treated spleen cells. 
Strain source of factor is in parentheses. 
§ Mean PFC of triplicate cultures. 
I[ Cells treated with inappropriate I-J antiserum plus C', i.e., serum of the wrong haplotype. Thus,  the 
a  b  studies with the H-2  and the H-2  mice act as reciprocals for one another. 
T Cells IfI-J + Material Is Removed from the Supernates (Table  VII).  Results  in Table  VII 
show  that  factor  preparations  made  in  the  presence  of both  I-J  +  and  I-J-;  Ly-2  cells 
(I-J+;Ly-2  T  cells  produce  Ly-2  TcsiF;I-J-;Ly-2  T  cells  produce  Ly-2  TsF)  can 1554  IMMUNOREGULATORY CIRCUITS THAT MODULATE  RESPONSIVENESS 
TABLE VI 
Spleen Cells  from B I O Strains Can Be Suppressed  by Factor Preparations Made by 
Cultured I-J- Ly-2 T Cells 
Exp.  Spleen cells  Treatment of cells making Ly-  PFC/cul- 




B lO.A  No factor added  1,500  Standard 
B10.A  NMS + C'  1,400  7 
B10.A  Anti-l-J  k (ASM-46) + C'  800  47 
B 10  No factor added  1,700  Standard 
B10  NMS + C'  1,700  0 
B10  Anti-I-J  h (ASM-5) + C'  340  80 
B !.0.A  No factor added  1,150  Standard 
B10.A  NMS + C'  1,300  0 
B10.A  Anti-I-J  k (ASM-46) + C'  300  77 
B 10  No factor added  2,100  Standard 
B10  NMS + C'  2,400  0 
Bt0  Anti-l-J  b (ASM-5) + C'  700  67 
B 10  No factor added  1,200  Standard 
B10  NMS + C'  1,100  8 
B10  Anti-I-J  b (ASM-5) + C'  100  93 
B10  Anti-I-J  b abs. 3R + C'll  1,200  0 
BI0  Anti-I-J  b abs. 5R + C'¶  300  75 
* 5 ×  10  s unprimed spleen cells. 
~:Culture supernate  from  in  vivo  primed  anti-Ly-I  plus C'-treated  spleen  cells. 
Treatment was done after in vivo immunization and before starting factor prepa- 
ration. Source of factor preparation was B10.A for experiments using B10.A mice 
and B6 for experiments using B 10 mice. 
§ Mean PFC of triplicate cultures. 
¶ Anti-I-J  b abs. 3R, sera ASM-5 absorbed with B10.A(3R) lymphocytes, i.e., specific 
absorption. 
[I Anti-I-J  b abs. 5R, sera ASM-5 absorbed with B 10.A(5R) lymphocytes, i.e., specificity 
control. 
suppress  unfractionated  B10  spleen cell  cultures  if the  biologically active  materials 
are  filtered  through  anti-I-J  columns  (experiments  B,  C,  H,  K,  and  L).  Results  in 
experiments H  and K  also show  that  the acid eluate obtained after filtration of the 
crude  supernate  through  the  anti-I-J columns renders  the  suppressor  factor  in  the 
filtrate functionally inactive (In :>20 experiments, we have not found any biological 
activity in these  eluates  unless TsF was  also  present  [see Table  IX  for  a  typical  re- 
sult].)  Experiment  K  shows additionally that  absorption of the anti-I-J  b serum with 
I-J  k cells does not remove the ability of serum to bind (and release)  I-J  b+ Ly-2 TcsiF 
(specificity control).  Normal  mouse  serum  (NMS)  control  columns did  not  remove 
TcsiF  activity  (experiments  B  and  L).  Thus,  removal  of I-J  +  material  (Ly-2 TcsiF) 
from Ly-2 factor preparations permits I-J- material (Ly-2 TsF) to suppress strain B 10 
responses, presumably as a  result of a  failure to activate the contrasuppression system. 
The  results in experiment L  of Table VII confirm the results presented  in Table  III 
demonstrating  that  B10  cells  are  as  easily  suppressed  as  B6  spleen  cells  when  the YAMAUCHI,  GREEN,  EARDLEY,  MURPHY,  AND  GERSHON 
TABLE  VII 
Spleen Cells  from BIO Strains Can Be Suppressed by Supemates  from Cultured 
Immune Ly-2 T Cells If I-J + Material is Removed  from the Factor Preparations 
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Spleen  PFC/cuI- 
Exp.  cells in  Ly-2 factor preparations~  ture§  Suppression 
culture* 
% 
B  B 10  -  1,000  Standard 
B10  +  (NMS [5R] filtrate)  900  10 
B10  +  (I-J eluate)l  I  240  76 
C 
K 
B 10  --  850  Standard 
B10  +  800  6 
B10  +  (I-J filtrate)¶  250  71 
B 10  -  1,400  Standard 
B10  +  1,200  14 
B10  +  (I-J filtrate)¶  500  64 
BI0  +  (I-J filtrate +  l-J eluate)l[  t,400  0 
B 10  -  1,200  Standard 
BI0  +  900  25 
B10  +  (l-J filtrate)**  300  75 
BI0  +  (I-J filtrate +  I-J eluate)[I  1,100  8 
B 10  +  1,000  Standard 
B10  +  (NMS [5R] filtrate)  900  10 
B10  +  (I-J filtrate)  250  81 
B6  -  1,300  Standard 
B6  +  (NMS [5R] filtrate)  450  65 
B6  +  (I-J filtrate)  250  81 
* 5 ×  10  s unprimed spleen cells. 
:~ (-)  without or (+) with culture supernate from in vivo primed anti-Ly-!  plus C'- 
treated spleen ceils. B6 mice were the strain source for all factors in experiment. 
§ Mean of triplicate cultures. 
[1 Acid eluate from anti-I-J  b immunoahsorhent column. 
** Ly-2 factor preparation passed over anti-I-J  b immunoabsorbent coated with serum 
that had been absorbed with I-J  k (B 10.A)  lymphocytes before column preparation. 
contrasuppressor circuit is quenched by removal of acceptor cells (Table III), as well 
as by removal of inducer signals (Table VII). 
Spleen Cells from  B I O Mice Can Be Suppressed by Supernates  from  Unfractionated Cultured 
Immune Ly-2 T Cells If the Supernates Are Absorbed with Cross-reacting  Heterologous E~ythrocytes 
(Table  VIII).  From previous studies, we knew that the anti-SRBC Ly-2 TsF could 
be absorbed with SRBC but not with HRBC.  2 We also had found that TcsiF could 
be absorbed with both SRBC and HRBC (4). We therefore tried to determine whether 
Ly-2 TcsiF in  the  B10  system  had  similar  cross-reactive antigenic  specificity. The 
results in Table VIII show that the material in the Ly-2 factor preparations responsible 
for inhibiting suppressor activity (Ly-2 TcsiF) in B 10 mice is more cross-reactive than 
is  Ly-2 TsF, i.e.,  Ly-2 TcsiF could be absorbed with  HRBC:  in three experiments, 
whereas  Ly-2 TsF  could  not.  The  absorption  had  some specificity, because  burro 
erythrocytes (BRBC)  failed to absorb  either activity from two factor preparations, 1556  IMMUNOREGULATORY  CIRCUITS THAT  MODULATE  RESPONSIVENESS 
TABLE VIII 
Spleen Cells  from B I O Mice Can Be Suppressed by Supernates  from Cultured 
Immune Ly-2 T Cells If HRBC-binding Material Is Removed 
Exp.  Spleen cells  Ly-2 factor  PFC/cul- 




B 10  -  1,400  Standard 
B10  +  1,200  14 
BI0  (SRBC)]  I  1,100  21 
B tO  (HRBC)  400  7 t 
B10  (BRBC)  1,200  14 
B 10  -  740  Standard 
BI0  +  760  0 
B 10  (SRBC)  850  0 
B 10  (H RBC)  300  59 
B 10  (BRBC)  850  0 
B6  -  2,400  Standard 
B6  +  1,200  50 
B6  (SRBC)  2,200  8 
B6  (HRBC)  1,100  54 
B6  (BRBC)  1, I00  54 
* 5 ×  106 unprimed spleen cells. 
:~ (-) without or (+) with culture supernatant from in vivo primed anti-Ly-1 
plus C'-treated B6 spleen cells. 
§ Mean of triplicate cultures. 
[I Ly-2 factor preparation absorbed with cells in parentheses. 
but  did from  a  third.  (Note: Table VIII, part b  of experiment I, where factors were 
also tested on B6 whole spleen. This demonstrates the inability of HRBC  and BRBC 
to absorb out suppressor factor under conditions where SRBC can.) Thus, removal of 
HRBC-binding  material  (Ly-2  TcsiF)  from  Ly-2  factor  preparations  permits  Ly-2 
TsF to suppress strain B 10 responses. 
Anti-I-J and Cross-reactive Erythrocytes  Have Similar Capacities  to Absorb  Contrasuppressor- 
inducing Activity (Table IX).  The results presented in Table IX show that HRBC  and 
an anti-I-J immunoabsorbent have similar abilities to absorb out the contrasuppressor- 
inducing  factor,  which  obscures  the  suppression  when  unfractionated  Ly-2  factor 
preparations  are  added  to  unfractionated  B10  spleen  cells.  In  addition,  they  show 
that  the eluate from  an  anti-I-J column  has no significant helper activity (compare 
group 6 with group  1) unless mixed with contrasuppressor depleted suppressor factor 
(compare group 7 with group 5). 
Taken  together,  these  data  demonstrate  that  the  failure  of  B10  strains  to  be 
suppressed by Ly-2  factor preparations  is a  result  of contrasuppression.  Thus,  Ly-2 
factor preparations contain two activities: (a) Ly-2 TsF, which suppresses responses of 
Ly-1  T  cells and  B  cells, is SRBC  specific, I-J-, and  is produced by I-J-;Ly-2 cells; 
(b) Ly-2 TcsiF, which induces Ly-1,2; I-J  + T  cells to express contrasuppressive activity, 
cross-reacts with  related heterologous erythrocytes, is I-J  +, and  is produced by I-J+; 
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TABLE IX 
Comparison of the Ability of a Cross-reacting Erythrocyte (HRBC) and an 
Anti-I-J Immunoabsorbent to Absorb Contrasuppressive-inducing Activity  and 
the Ability of I-J + Material to Reconstitute Such Activity 
PFC/cul- 
Group  Ly-2 factor preparation*  ture:~  Suppression 
% 
1  -  2,900  Standard 
2  +  3,200  0 
3  (SRBC)§  3,400  0 
4  (HRBC)§  1,300  55 
5  (antM-J) H  1,100  62 
6  Eluate from anti-I-J¶  3,700  0 
7  Mixture of groups 5 and 6  4,000  0 
* (-)  without  or  (+)  with culture supernate  from in  vivo primed anti-Ly-1 
plus C'-treated B6 spleen cells. 
:[: Mean of triplicate cultures of 5 ×  l0  s B6 spleen cells. 
§ Ly-2 factor preparation absorbed with cells in ~arentheses. 
[] Ly-2 factor preparation passed over an anti-I-J  immunoabsorbent. 
¶ Acid eluate from column used in group 5. 
Discussion 
Results presented here show that the apparent failure of B 10 mice to respond to the 
Ly-2 suppressor factor preparation we have produced is not a result of an inability of 
this  factor to act  on its  acceptor cell.  The lack of response is a  result of an  active 
process, induced by I-J  + material (Ly-2 TcsiF), which serves to functionally block the 
biological  activity  of I-J-  suppressor  material  (Ly-2  TsF).  The  blocking  activity 
(contrasuppression) results from the activation of I-J+; Qa- 1  +; Ly- 1,2 contrasuppressor 
cells by Ly-2 TcsiF. Spleen cells of B 10 strains will exhibit the same sensitivity to Ly- 
2 suppressor factor preparations as do cells of other mouse strains if: (a) the Ly-2 cells 
that are producing the factor preparations are treated with an anti-I-J serum and C' 
(eliminating I-J  + cells producing Ly-2 TcsiF, but not I-J- cells producing Ly-2 TsF); 
(b)  the supernates  from cultured  unfractionated  Ly-2 cells are passed  over anti-I-J 
immunoabsorbent columns (removing I-J  + by Ly-2 TcsiF but not I-J-;Ly-2 TsF); (c) 
the supernates are absorbed with HRBC  (Ly-2 TcsiF binds  HRBC, Ly-2 TsF does 
not),  or  (d)  the  acceptor  cells  that  are  induced  by  Ly-2  TcsiF  are  removed  by 
treatment with any of the following antisera: Ly-1, Ly-2, I-J, or Qa-1. 
The  I-J  +  cell-free  material  (TcsiF)  that  activates  the  contrasuppressor  cell  is 
probably composed of an antigen-recognizing moiety (Tables VIII and IX), and an 
IoJ  gene-controlled alloantigen  (Tables VII  and  IX). That the  antigen-recognizing 
portion of the Ly-2 TcsiF differs from the antigen-specific portion of the Ly-2 TsF (in 
that the former cross-reacts with other heterologous erythrocytes  5 whereas the latter 
does not  2) is of some interest. Why (and how) the Ly-2 cell that produces TcsiF should 
(or can) express a different variable region gene product than does the Ly-2 cell that 
produces TsF are important questions. Perhaps the regulatory activities of suppression 
and  contrasuppression  had  different  phylogenetic  origins.  It  is  known  that  high 
5 The pattern of the cross-reactions of  TcsiF with different types of heterologous mammalian erythrocytes 
shows variation from batch to batch. 1558  IMMUNOREGULATORY  CIRCUITS THAT MODULATE RESPONSIVENESS 
affinity antibodies exhibit more cross-reactions than do low affinity antibodies  (10- 
15) and that high affinity antibodies appeared relatively late in phylogeny (16). Thus 
it  is  possible  that  the phylogenetic appearance of the ability to make high affinity 
antibodies coevolved with the development of the contrasuppressor circuit and that 
this is reflected in their cross-reactivity patterns.  High affinity antibodies are partic- 
ularly thymus dependent (15,  17) and appear late in the immune response (18). Thus, 
inhibition of the suppression produced by antibody feedback (19)  (which is affinity 
dependent [20]; i.e., the higher the affinity, the greater the feedback) may be required 
for  the  continued  progression  of the  immune  response  to  levels  of high  affinity. 
Contrasuppression could be the mechanism by which this is brought about. 
Whether the I-J gene product on the Ly-2 TcsiF is the same as the I-J gene products 
on other biologically active factors is now under investigation.  However, this seems 
unlikely, based on theoretical grounds, as well as on preliminary experimental data 
that  suggest  that  the  I-J  gene  product  expressed  on  cells  in  the  contrasuppressor 
circuit is different from the I-J product expressed on cells  in the suppressor circuit. 
The observation that the Ly-2 TsF and the cell that produces it cannot be removed 
with any of the anti-I-J serum we have used is a consistent one (4) 2' 4 even though the 
Ly-1 inducer cell and Ly-1,2 amplifier cells in the suppressor circuit are I-J  + and can 
be removed with these reagents (8).6 Thus, although there may be numerous cells and 
cell products in the suppressor circuit that are I-J  +, the final Ly-2 effector cell may 
express too little of an I-J determinant to be detected by our reagents, or may express 
a unique I-J determinant that our anti-I-J sera fail to recognize. None of the previous 
reports on I-J  + TsF have shown that these materials express suppressive activity in the 
absence of Ly-2  + cells.  In fact, those experiments that have been done to determine 
the acceptor cell  for I-J  + factors have found that  these  factors act  as  amplifiers or 
inducers of suppression rather than as molecules that suppress directly (2, 21). 
Whereas  our results  show that  the  in  vitro  immune  response of B10  mice  is  an 
excellent example for demonstrating the activity of the contrasuppressor circuit and 
for investigating the cellular interactions involved in the generation of contrasuppres- 
sor activity, the biological significance of the results  from these studies  is less clear. 
There is no reason to suspect that mice with B 10 background genes have significantly 
abnormal immunoregulatory mechanisms. Thus, the results we have presented may 
be  either  trivial  or  in  vitro  artifacts.  This  is  unlikely,  however,  because  in  vivo 
inoculation of in vitro generated contrasuppressor cells  can turn a  tolerogenic signal 
into an immunogenic one.  7 Nevertheless, a  great deal of work is required before the 
precise  role  of modulation  by cells  of the  contrasuppressor  circuit  in  the  in  vivo 
immune response can be ascertained. 
The  exact  importance  of any  of the  immunoregulatory circuits  or  interactions 
described  by  us  or  others  in  the  overall  scheme  of in  vivo  immunoregulation  is 
uncertain. However, one cannot do the experiments to determine the in vivo impor- 
tance of immunoregulation unless  one recognizes the existence of the various inter- 
actions that  take  place within  these  immunoregulatory circuits.  In considering the 
Yamauchi, K., D. B. Murphy, H. Cantor, and R. K. Gershon. Analysis  of antigen specific, Ig restricted 
cell free material made by I-J  + Ly-1 cells (Ly-1 TsiF) that induces Ly-2  + cells to express suppressive 
activity. Manuscript submitted for publication. 
7  Ptak, W., D. R. Green, S. K. Durum, A. Kimura, D. B. Murphy, and R. K. Gershon. Immunoregulatory 
circuits that modulate responsiveness to suppressor cell signals: contrasuppressor  cells can convert an in vivo 
tolerogenic signal into an immunogenic  one. Manuscript submitted for publication. YAMAUCHI, GREEN,  EARDLEY, MURPHY,  AND GERSHON  t559 
potential  physiological importance of the cell interactions we  have described,  it  is 
important to note that we have found similar activities in all mice strains studied ([5, 
6];  and  our  unpublished  observations).  The  B10  mouse  strain,  which  acts  as  a 
phenotypically exaggerated example when studied in vitro, makes it useful for study, 
but  the circuit we have described is by no means confined to mice expressing B10 
background genes. In fact, our preliminary results suggest that the expression of long- 
term memory by T  cells requires that they develop increased resistance to suppressor 
mechanisms, and that the part of the contrasuppressor circuit we have analyzed in 
B 10 mice plays an essential role in that development. 
Thus, if we assume future work will establish the importance of the contrasuppressor 
circuit in vivo, the main question raised by our results (which requires an answer) is: 
Why do B10 T  cells respond more actively to contrasuppressor inducer factors than 
do T  cells from mice of other strains? There are two general classes of explanations for 
this phenomenon. One is that the B 10 cells that are activated by the contrasuppressor- 
inducing factor (or other cells with which these acceptor cells communicate) are truly 
hyperactive when  put  into  tissue  culture.  The second  class  of explanation  is  that 
cultured B10 spleen cells lack the activity of another type of Ly-2  + modulatory cell, 
which has the job of helping suppressor factors work. This help may be necessary to 
counteract or balance the activity of cells in the contrasuppressor circuit. The notion 
of auxiliary cells that  may help suppressors work has been previously suggested  (2, 
21-23). It is possible the TsF of Taniguchi et al. (1) and Tada et al. (2), which fails to 
work on B 10 spleen cells, may be the product of these auxiliary cells. If this is the case, 
because the TsF of Tada et al. fails to bind to B10 acceptor cells (1), it is likely that 
an absence of auxiliary suppressor cell activity is a  major factor in the expression of 
an apparent  in vitro hyperactivity of contrasuppression  in  B10 mice. Obviously, if 
this is true, the need for auxiliary cells to make suppression manifest should disappear 
when the contrasuppression system is quenched by any of the techniques listed above. 
The notion that auxiliary, or perhaps more aptly termed "modulatory" cells, deter- 
mine in part the sensitivity of effector cells to suppressor cell signals has been noted 
in circuits other than those which exert immunoregulatory effects (e.g., the nervous 
system [24]). 
Whatever the lesion(s)  is,  that  makes the contrasuppression system of B10 strain 
mice so dominant, it presents an ideal system for obtaining information that will be 
helpful in deciphering the complex series of interactions between the numerous subsets 
of T  cells that are responsible for the finely tuned process of immune regulation. 
Summary 
The in vitro antibody response of spleen cells from B l0 strain mice is not suppressed 
by factor preparations made by primed Ly-2 T  cells, although these preparations can 
suppress the in vitro antibody response of spleen cells from other mouse strains (1-3).  2 
The factor preparations from Ly-2 cells contain at least two separable activities: one 
that  acts  as  a  suppressor moiety  (Ly-2 T  cell suppressor  factor [Ly-2 TsF])  and  a 
second  factor that  acts as an  inducer of contrasuppression  (Ly-2 TcsiF);  the latter 
initiates a series of cellular interactions that leads to the inhibition of suppression that 
we refer to as contrasuppression. 
Removal of components (either cellular or humoral) of the contrasuppressor circuit 
makes spleen cells from B10 strain  mice as easily suppressible as are those of other 1560  IMMUNOREGULATORY CIRCUITS THAT MODULATE RESPONSIVENESS 
mouse strains.  Thus, removal of the contrasuppressor inducer cell and/or its biologi- 
cally active product with  the use of an anti-I-J serum, or removal of the functional 
acceptor cell of the inducer cell with the same or other  (Ly-2;Qa-1) antisera  breaks 
the B10 suppressor barrier.  Contrasuppressive activity, but not helper activity can be 
eluted  from anti-I-J immunoabsorbents.  The addition  of B10 T  cells to either B6 or 
B 10 spleen cell cultures deprived of acceptor cells for the TcsiF reconstitutes contra- 
suppression more efficiently than does the addition of C57BL/6 T  cells. Ly-2 TcsiF is 
more cross-reactive than  is Ly-2 TsF so that  absorption  of factor preparations  from 
sheep  erythrocyte-primed  Ly-2  cells  with  horse  erythrocytes  also  breaks  the  B10 
suppressor barrier. 
The hyperresponsiveness of splenic T  cells from B10 strains to Ly-2 TcsiF may be 
an in vitro exaggeration of a  normal in vivo process. Thus it is possible that one can 
take advantage of this unusual situation to help dissect out the cellular and subcellular 
components of T  cell circuits that modulate sensitivity to immunoregulatory signals. 
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